ekosonic endovascular device

The Ekosonic Endovascular Device is a catheter-based system designed for ultrasound-assisted thrombolysis. It is intended for the controlled infusion of thrombolytics into the peripheral vasculature and pulmonary arteries, aiding in the dissolution of thrombi.

Commonly used in the management of acute pulmonary embolism and acute limb ischemia, the device facilitates thrombolysis in patients who are hemodynamically unstable or at risk of vascular complications. It is often employed in conjunction with other supportive measures like ECMO.

The literature includes 15 studies, comprising case series and other study types, published between 2020 and 2022. These studies explore the device's efficacy and safety in various clinical scenarios, focusing on thrombolysis outcomes.

Published studies report that the Ekosonic Endovascular Device effectively resolves ischemia and restores normal blood flow in affected arteries. In cases of acute limb ischemia, symptoms were resolved, and angiographic control showed normal flow. The device has also been used successfully in pulmonary embolism cases, contributing to right ventricular recovery.

Reported complications include local deficits, although patients were discharged without any long-term deficits. The safety profile is generally favorable, with no significant adverse events reported in the available studies.

The evidence is limited by the small number of studies and the lack of large-scale randomized controlled trials. Further research is needed to establish long-term outcomes and to compare the device's efficacy with other thrombolytic strategies.